M1 receptor agonism, a possible treatment for cognitive deficits in schizophrenia.
Dean
Brian
B
D001923:Brain Chemistry; D003072:Cognition Disorders / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D018721:Muscarinic Agonists / Q000627:therapeutic use*; D018727:Muscarinic Antagonists / Q000494:pharmacology; D010890:Pirenzepine / Q000494:pharmacology; D043643:Receptor, Muscarinic M1 / Q000187:drug effects* / Q000378:metabolism; D012559:Schizophrenia / Q000150:complications*; D012565:Schizophrenic Psychology
D018721:Muscarinic Agonists; D018727:Muscarinic Antagonists; D043643:Receptor, Muscarinic M1; D010890:Pirenzepine